The FDA’s Antivirals Drug Advisory Committee voted unanimously in favor of agency approval for the investigational drug, boceprevir, in hopes of offering a new treatment option for the 3 to 4 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results